How do you talk to patients about clinical trials?
I care deeply about clinical trials but have always struggled on how to approach this topic. I would really appreciate tips from those of you who have figured this out!
Answer from: Medical Oncologist at Community Practice
I try to incorporate the clinical trial idea into the standard of care recommendation/discussion at the time of initial treatment decision making. After making a standard of care rx recommendation, I tell patients that my recommendation is based upon this treatment being the winner of a pr...
Answer from: Medical Oncologist at Academic Institution
I tend to express clinical trials as a normal part of discussion. Using the same skills as in discussing hospice, I utilize the ASK-TELL-ASK or SPIKES model.
During my interview, I ask (Ask of ASK-TELL-ASK or P of SPIKES) patients what they know about their cancer, their treatment options, t...
Comments
Medical Oncologist at Saint Elizabeth Regional Medical Center Very nice summary.
Answer from: Radiation Oncologist at Academic Institution
Some additional thoughts relevant to clinical trials in the multi-modality, curative intent, initial management setting:
1. It is unbelievably helpful if the patient and family hear the same message about best standard option, best clinical trial option, and why the clinical trial seems like the be...
Answer from: Medical Oncologist at Academic Institution
I discuss clinical trials as a potential treatment option after discussing a standard of care option. For some patients, standard of care isn’t an option. Usually in the first line setting, a trial drug (or placebo) is given in conjunction with standard of care, so the main downside is increas...
Answer from: Medical Oncologist at Community Practice
For patients in the metastatic settings where standard of care is approved and we have ample data of its efficacy and potential toxicity, I would definitely be in favor of delivering SOC first, and I will mention then that when/if this first line therapy fails, we have many other potential drugs in ...